Literature DB >> 10377262

Processing of normal lysosomal and mutant N-acetylgalactosamine 4-sulphatase: BiP (immunoglobulin heavy-chain binding protein) may interact with critical protein contact sites.

T M Bradford1, M J Gething, R Davey, J J Hopwood, D A Brooks.   

Abstract

The lysosomal hydrolase N-acetylgalactosamine-4-sulphatase (4-sulphatase) is essential for the sequential degradation of the glycosaminoglycans, dermatan and chondroitin sulphate and, when deficient, causes the lysosomal storage disorder mucopolysaccharidosis type VI. The cysteine at codon 91 of human 4-sulphatase was identified previously as a key residue in the active site of the enzyme and was mutated by site-directed mutagenesis to produce a 4-sulphatase in which cysteine-91 was replaced by a threonine residue (C91T). The C91T mutation caused a loss of 4-sulphatase activity, a detectable protein conformational change and a lower level of intracellular 4-sulphatase protein [Brooks, Robertson, Bindloss, Litjens, Anson, Peters, Morris and Hopwood (1995) Biochem. J. 307, 457-463]. In the present study, we report that C91T is synthesized normally in the endoplasmic reticulum as a 66 kDa glycosylated protein, which is very similar in size to wild-type 4-sulphatase. However, C91T neither underwent normal Golgi processing, shown by lack of modification to form mannose 6-phosphate residues on its oligosaccharide side chains, nor did it traffic to the lysosome to undergo normal endosomal-lysosomal proteolytic processing. Instead, C91T remained in an early biosynthetic compartment and was degraded. The molecular chaperone, immunoglobulin binding protein (BiP), was associated with newly-synthesized wild-type and mutant 4-sulphatase proteins for extended periods, but no direct evidence was found for involvement of BiP in the retention or degradation of the C91T protein. This suggested that prolonged association of mutant protein with BiP does not necessarily infer involvement of BiP in the quality control process, as previously implied in the literature. The predicted BiP binding sites on 4-sulphatase map to beta-strands and alpha-helices, which are co-ordinated together in the folded molecule, indicating that BiP interacts with critical protein folding or contact sites on 4-sulphatase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377262      PMCID: PMC1220347     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

1.  Affinity panning of a library of peptides displayed on bacteriophages reveals the binding specificity of BiP.

Authors:  S Blond-Elguindi; S E Cwirla; W J Dower; R J Lipshutz; S R Sprang; J F Sambrook; M J Gething
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

2.  Two mutations affecting the transport and maturation of lysosomal alpha-glucosidase in an adult case of glycogen storage disease type II.

Authors:  M M Hermans; M A Kroos; E de Graaff; B A Oostra; A J Reuser
Journal:  Hum Mutat       Date:  1993       Impact factor: 4.878

3.  BiP binds type I procollagen pro alpha chains with mutations in the carboxyl-terminal propeptide synthesized by cells from patients with osteogenesis imperfecta.

Authors:  S D Chessler; P H Byers
Journal:  J Biol Chem       Date:  1993-08-25       Impact factor: 5.157

4.  Components and proteolytic processing sites of arylsulfatase B from human placenta.

Authors:  T Kobayashi; K Honke; T Jin; S Gasa; T Miyazaki; A Makita
Journal:  Biochim Biophys Acta       Date:  1992-10-20

5.  Juvenile form of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). A C-terminal extension causes instability but increases catalytic efficiency of arylsulfatase B.

Authors:  G Arlt; D A Brooks; D Isbrandt; J J Hopwood; J Bielicki; T M Bradford; C A Bindloss-Petherbridge; K von Figura; C Peters
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157

6.  Two site-directed mutations abrogate enzyme activity but have different effects on the conformation and cellular content of the N-acetylgalactosamine 4-sulphatase protein.

Authors:  D A Brooks; D A Robertson; C Bindloss; T Litjens; D S Anson; C Peters; C P Morris; J J Hopwood
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

7.  Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator.

Authors:  S Pind; J R Riordan; D B Williams
Journal:  J Biol Chem       Date:  1994-04-29       Impact factor: 5.157

8.  Mutant (delta F508) cystic fibrosis transmembrane conductance regulator Cl- channel is functional when retained in endoplasmic reticulum of mammalian cells.

Authors:  E A Pasyk; J K Foskett
Journal:  J Biol Chem       Date:  1995-05-26       Impact factor: 5.157

9.  Carbohydrate-deficient glycoprotein syndrome (CDGS)--glycosylation, folding and intracellular transport of newly synthesized glycoproteins.

Authors:  T Marquardt; K Ullrich; P Zimmer; A Hasilik; T Deufel; E Harms
Journal:  Eur J Cell Biol       Date:  1995-03       Impact factor: 4.492

10.  Disulfide bond formation during the folding of influenza virus hemagglutinin.

Authors:  M S Segal; J M Bye; J F Sambrook; M J Gething
Journal:  J Cell Biol       Date:  1992-07       Impact factor: 10.539

View more
  4 in total

1.  Characterization of beta-galactosidase mutations Asp332-->Asn and Arg148-->Ser, and a polymorphism, Ser532-->Gly, in a case of GM1 gangliosidosis.

Authors:  S Zhang; R Bagshaw; W Hilson; Y Oho; A Hinek; J T Clarke; J W Callahan
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

2.  A phaseolin domain involved directly in trimer assembly is a determinant for binding by the chaperone BiP.

Authors:  Ombretta Foresti; Lorenzo Frigerio; Heidi Holkeri; Maddalena de Virgilio; Stefano Vavassori; Alessandro Vitale
Journal:  Plant Cell       Date:  2003-09-24       Impact factor: 11.277

3.  Analysis of normal and mutant iduronate-2-sulphatase conformation.

Authors:  Emma Parkinson-Lawrence; Christopher Turner; John Hopwood; Doug Brooks
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

4.  Mutations in ARSB in MPS VI patients in India.

Authors:  Juby Mathew; Sujatha M Jagadeesh; Meenakshi Bhat; S Udhaya Kumar; Saravanamuthu Thiyagarajan; Sudha Srinivasan
Journal:  Mol Genet Metab Rep       Date:  2015-07-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.